Skip to main content
. 2013 Oct 8;38(1):73–82. doi: 10.1007/s00264-013-2123-y

Table 4.

Results for infection (group 1) and control (group 2) groups

Group 1 (24 patients) Group 2 (24 patients) P value*
Follow-up duration in months (range) 59 ± 21 (18–96) 55 ± 21 (18–96) 0.57
Operative duration (min) 74 ± 14 71 ± 11 0. 42
Tegner activity acale Preoperative 8 (7–9) 8 (7–8) 0.48
Postinjury 3 (2–4)*** 3 (2.25-4)*** 0.89
1 year 5.5 (4–7)*** 7 (6–8)*** 0.001
Final 5.5 (4–7) 7 (6–8) 0.004
P value** <0.017 <0.017
IKDC ranking Preoperative 3.5 (3–4) 4 (3–4) 0.57
1 year 2 (1–2)*** 2 (1–2)*** 0.82
Final 2 (1–2.75) 1.5 (1–2) 0.35
P value** <0.025 <0.025
Radiographic IKDC Preoperative 1 (1–1) 1 (1–1) 0.99
1 year 1 (1–1) 1 (1–1) 0.99
Final 1 (1–2)*** 1 (1–1) 0.09
P value** <0.025 <0.025
Modified Lysholm score Preoperative 61(55–69) 60 (57–63) 0.68
1 year 87.5(76–95)*** 89 (85–95)*** 0.08
Final 85(72–93) 90 (83–95) 0.10
P value** <0.025 <0.025
KOOS Score KOOS symptoms 86 (69–89) 87 (76–95) 0.39
KOOS pain 82 (75–93) 89 (84–97) 0.07
KOOS daily 96 (82–99) 96 (91–99) 0.28
KOOS sports 90 (65–99) 95 (86–99) 0.45
KOOS QOL 84 (63–100) 100 (77–100) 0.20
Percentage(%) of improvement of modified Lysholm score 32.4 % ± 33 47.4 % ± 19.8 0.07

Data are median (25–75th percentile) or mean ± standard deviation, except where stated

IKDC International Knee Documentation Committee, KOOS Knee Injury and Osteoarthritis Outcome Score, QOL quality of life

* Student t test, Mann–Whitney U test, or Kruskall–Wallis test used as appropriate

** Friedman test with post hoc analysis

*** Significantly different from the preceding time period